Introducing
Abiliti™ Overnight Therapeutic Lenses for Myopia Management
Abiliti™ Overnight lenses are approved for myopia control and have been shown to reduced axial elongation in myopic children by 0.28mm, on average, over a 2-year period.*,1-4 Worn overnight, these lenses temporarily reshape the cornea 5-8, and allow patients to see clearly the next day after being worn overnight.†,9 Each lens is specifically designed to fit the unique shape of each patient's unique corneal shape and prescription.10 Abiliti™ Overnight lenses can help manage the progression of your child's myopia.
Mode of action:
Steepening of the peripheral cornea which accompanies central corneal flattening may reduce peripheral retinal hyperopia.11
Why treat myopia with Abiliti™ Overnight lenses?
FitAbiliti™ experiential fitting software
Leverages the latest technology to offer a first fit success rate of approximately 90% for spherical prescriptions‡ and 95% for with the rule astigmatic prescriptions.§,8,11
Lifestyle benefit with glasses- free during daytime
Significant improvement in vision-related quality of life for patients, compared to single vision spectacles.2
Astigmatism coverage
Approved to treat corneal astigmatism up to 2.50D.9
Comfort usually not an issue
Sufficient corneal oxygenation provides comfortable, safe wear with a DK of 182.9
As part of our comprehensive treatment approach with Abiliti™ portfolio, we will also offer FitAbiliti™ lens-fitting software for eye care professionals:
A user-friendly software designed to ease the entire management process for you in fitting Abiliti™ Overnight lenses and monitoring your patient’s myopia progression over time.
REFERENCES
*.Compared to single vision spectacles.
†.Reducing refractive error up to 4.00D and up to 2.50D of astigmatism.
‡.Final lens fit is determined by the ECP – software is for decision support only.
§.The lens is approved for correcting astigmatism of up to 2.50D.
1. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13. 2012;53(11):7077– 85.
2. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8).
3. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7.
4. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co- Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens.
5. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2).
6. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7.
7. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.
8. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72.
9. Data on File 2021. Menicon CE technical file.
10. Data on File 2021 Menicon Design History file.
11. Chan KY, Cheung SW, Cho P. Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children. Cont Lens Anterior Eye. 2012;35(4):180-184. doi: 10.1016/j.clae.2012.01.
Important safety information:
ACUVUE® Abiliti™ Overnight Therapeutic (tisilfocon A) Contact Lenses are indicated for use in the management of myopia. They are indicated for overnight wear for the temporary reduction of myopia and should only be disinfected using a chemical disinfection system. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems, or if patients have any allergy to any ingredient in a solution which is to be used to care for these lenses. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-896-3233, or by visiting www.seeyourabiliti.com.
PP2021ABLM4035
†.Reducing refractive error up to 4.00D and up to 2.50D of astigmatism.
‡.Final lens fit is determined by the ECP – software is for decision support only.
§.The lens is approved for correcting astigmatism of up to 2.50D.
2. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8).
3. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7.
4. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co- Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens.
5. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez- Ortega R. Short-term changes in ocular biometry and refraction after discontinuation of long-term orthokeratology. Eye Contact Lens. 2014;40(2).
6. Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye [Internet]. 2017/01/01. 2017;40(2):82–7.
7. Lau JK, Vincent SJ, Cheung SW, Cho P. The influence of orthokeratology compression factor on ocular higher-order aberrations. Clin Exp Optom. 2020 Jan; 103(1):123-128.
8. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72.
9. Data on File 2021. Menicon CE technical file.
10. Data on File 2021 Menicon Design History file.
11. Chan KY, Cheung SW, Cho P. Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children. Cont Lens Anterior Eye. 2012;35(4):180-184. doi: 10.1016/j.clae.2012.01.
ACUVUE® Abiliti™ Overnight Therapeutic (tisilfocon A) Contact Lenses are indicated for use in the management of myopia. They are indicated for overnight wear for the temporary reduction of myopia and should only be disinfected using a chemical disinfection system. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems, or if patients have any allergy to any ingredient in a solution which is to be used to care for these lenses. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-800-896-3233, or by visiting www.seeyourabiliti.com.
REFERENCES
